title: Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 2: a status report on topical agents.
abstract: A variety of topical therapies have been utilized in the treatment of rosacea. In part 2 of this 5-part series, topical agents that have been utilized in the treatment of the common clinical presentations of rosacea, including those that have been approved by the US Food and Drug Administration (FDA) as well as alternative agents, are reviewed. It is important to note that adjunctive skin care and photoprotection are integral components of rosacea treatment that may assist in optimizing therapeutic outcomes.
authors.affiliation: qdelrosso@yahoo.com.
authors.forename: James Q
authors.initials: JQ
authors.lastname: Del Rosso
authors.forename: Diane
authors.initials: D
authors.lastname: Thiboutot
authors.forename: Richard
authors.initials: R
authors.lastname: Gallo
authors.forename: Guy
authors.initials: G
authors.lastname: Webster
authors.forename: Emil
authors.initials: E
authors.lastname: Tanghetti
authors.forename: Larry
authors.initials: L
authors.lastname: Eichenfield
authors.forename: Linda
authors.initials: L
authors.lastname: Stein-Gold
authors.forename: Diane
authors.initials: D
authors.lastname: Berson
authors.forename: Andrea
authors.initials: A
authors.lastname: Zaenglein
mesh_terms: D000279:Administration, Cutaneous; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D017277:Drug Approval; D006801:Humans; D017410:Practice Guidelines as Topic; D012393:Rosacea / Q000188:drug therapy* / Q000473:pathology; D017592:Skin Care / Q000379:methods; D012955:Societies, Medical; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D003879:Dermatologic Agents